For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Prostate cancer screening: Life-saving or unnecessary tests?
+Practice
In print
CASELOAD
Prostate cancer screening: Life-saving or unnecessary tests?
Wednesday 31 August 2022, 12:35 AM

Digital rectal examination is never an easy sell, even at the best of times [Image: Bojan89 on iStock]
We all recognise the life-saving value of early detection of potentially deadly cancers, but does that mean prostate cancer should be routinely screened for? GP Jonathan Bentley discusses what patients need to know to make an informed decision
Key points, Prostate cancer screening is still a grey area, but patients over age 40 with a first-degree relative with prostate cancer, and patients over 50, shou, Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.